Professor Andrew M. Wardley
0000-0002-9639-0888
4 papers found
Refreshing results…
Comparison of circulating tumor DNA assays for Molecular Residual Disease detection in early-stage triple negative breast cancer
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)
Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Missing publications? Search for publications with a matching author name.